Masterarbeit, 2015
51 Seiten, Note: 1.1
1. Introduction
2. Literature Review
2.1 Overview
2.1.1 History
2.2 Single-Use Technology (SUT)
2.2.1 Advantages of SUT
2.2.2 Concerns with SUT
2.3 Regulatory Outlook
2.4 Primary Data
3. Current Methodologies for E&L testing
3.1 Extractable and Leachable studies
3.1.1 Solvent selection
3.1.2 Worst-case conditions
3.2 Extraction Techniques
3.3 Analytical techniques
3.4 Evaluation of Data
3.5 Leachables Studies
3.5.1 Application-specific evaluation
4. Regulatory Perspective
4.1 Official guidance documents
4.2 Industry groups contributions
4.3 Current Regulatory Outlook
5. Risk Assessment & Current Best Practice
5.1 Risk Identification
5.2 Risk Analysis
5.2.1 Quality by Design
5.3 Risk Control
5.4 Risk reduction
6. Conclusion
6.1 Discussion
6.2 Future trends and improvements
7. Bibliography
8. Appendices
8.1 Appendix – A
8.2 Appendix – B
8.3 Appendix – C
8.4 Appendix – D
8.5 Appendix – E
The primary research objective of this work is to critically evaluate current practices regarding Extractable and Leachable (E&L) assessments within Single-Use Systems (SUS), aiming to identify industry-wide challenges and propose paths toward standardization and improved patient safety.
3.1.1 Solvent selection
In terms of mimicking or modelling solutions for an extractables study, the principle of “like dissolves like” should be applied. This means that the likely leachable compounds that may be present in the single-use component would have a certain affinity for the chosen solvent. This may be due to similar functionality, polarity, or solubility for instance. The chosen solvent should be capable of interacting with the pharmaceutical matrix causing the migration of extractables from the interior towards the surface of the material. The use of organic solvents is known to produce a swelling effect which causes the pore size of the matrix to enlarge and thus, facilitate the migration of these compounds.
In order to select a relevant model solution, the constituents of the process fluid and its overall characteristics must first be examined. The Product Quality Research Institute (PQRI) recommends that solvent selection should begin with knowledge of the test article function, its constituents, and drug product formulation. In relation to the characteristics of the process fluid, the following would be important questions, is the process fluid highly aqueous, organic, oily, or does it possess an extreme pH. The answers to these questions would narrow the choice of potential solvents to one that possesses similar properties. It is proposed that any non-volatile constituents in the process fluid which is greater than 10% should be modelled with a volatile equivalent. In this way, a model is achieved that has equal or greater extracting strength and the same selectivity for leachables as the original process fluid.
Although water is one of the main constituents of many drug product formulations, it is a poor extraction solvent by itself for monomers, oligomers, and polymer additives. A combination of water with an organic solvent is suggested to achieve a more powerful extraction potential. In the same way, organic solvents are chosen with a wide range of polarities and boiling points, it is equally important that water of varying pH is used also. Similarly, water of different acidity or basicity can be viewed as different organic solvents with different solvating power which is required to evaluate a full suite of potential extractable compounds (Feinberg et al., 2012).
1. Introduction: Presents the growth of Single-Use Systems in biomanufacturing and introduces the central research problem regarding E&L contaminants.
2. Literature Review: Details the history, advantages, and concerns associated with SUT, while examining the regulatory uncertainty and the current state of industry data.
3. Current Methodologies for E&L testing: Evaluates scientific approaches to extraction, solvent selection, and analytical characterization of components.
4. Regulatory Perspective: Discusses the legislative basis for E&L testing and the role of various industry groups in driving standardization.
5. Risk Assessment & Current Best Practice: Focuses on the implementation of risk management, Quality by Design (QbD), and supply chain control to minimize safety risks.
6. Conclusion: Summarizes the study's findings and outlines future trends, emphasizing the need for standardized protocols to ensure patient safety.
Single-Use Systems, Extractables, Leachables, Biopharmaceutical Manufacturing, Risk Assessment, Quality by Design, Regulatory Standards, Solvent Selection, Patient Safety, Supply Chain, Analytical Techniques, Polymer Compatibility.
This research provides a comprehensive account of the challenges associated with the assessment of Extractable and Leachable (E&L) compounds in the biopharmaceutical industry, particularly concerning the adoption of Single-Use Systems.
The work covers the transition from stainless steel to single-use technology, the specific risks of chemical migration, the impact on drug quality, and the urgent industry need for standardized testing and risk management.
The goal is to critically evaluate existing research on SUT, highlight concerns regarding vendor-supplied data, and examine current best practices for ensuring patient safety and regulatory compliance.
The study examines controlled extraction studies (CES), the application of "like dissolves like" for solvent selection, extraction techniques such as maceration and reflux, and various hyphenated analytical methods like GC-MS and LC-MS.
The main body focuses on existing industry literature, methodologies for characterizing extractables, current regulatory guidance, risk assessment models, and strategies for risk control within the supply chain.
Key terms include Single-Use Systems, Extractables, Leachables, Biomanufacturing, Quality by Design, Risk Assessment, and Regulatory Compliance.
The author argues for the adoption of standardized protocols for extractables testing and enhanced communication between vendors and end-users regarding polymer composition and change control.
QbD is presented as a vital strategy for integrating quality into the manufacturing process from the start, rather than relying on final-product testing to identify potential leachable issues.
Der GRIN Verlag hat sich seit 1998 auf die Veröffentlichung akademischer eBooks und Bücher spezialisiert. Der GRIN Verlag steht damit als erstes Unternehmen für User Generated Quality Content. Die Verlagsseiten GRIN.com, Hausarbeiten.de und Diplomarbeiten24 bieten für Hochschullehrer, Absolventen und Studenten die ideale Plattform, wissenschaftliche Texte wie Hausarbeiten, Referate, Bachelorarbeiten, Masterarbeiten, Diplomarbeiten, Dissertationen und wissenschaftliche Aufsätze einem breiten Publikum zu präsentieren.
Kostenfreie Veröffentlichung: Hausarbeit, Bachelorarbeit, Diplomarbeit, Dissertation, Masterarbeit, Interpretation oder Referat jetzt veröffentlichen!

